---
title: Circular extrachromosomal DNA promotes tumor heterogeneity in high-risk medulloblastoma
date: '2023-11-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/37945900/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20231110170941&v=2.17.9.post6+86293ac
source: heidelberg[Affiliation]
description: Circular extrachromosomal DNA (ecDNA) in patient tumors is an important
  driver of oncogenic gene expression, evolution of drug resistance and poor patient
  outcomes. Applying computational methods for the detection and reconstruction of
  ecDNA across a retrospective cohort of 481 medulloblastoma tumors from 465 patients,
  we identify circular ecDNA in 82 patients (18%). Patients with ecDNA-positive medulloblastoma
  were more than twice as likely to relapse and three times as likely to die within
  ...
disable_comments: true
---
Circular extrachromosomal DNA (ecDNA) in patient tumors is an important driver of oncogenic gene expression, evolution of drug resistance and poor patient outcomes. Applying computational methods for the detection and reconstruction of ecDNA across a retrospective cohort of 481 medulloblastoma tumors from 465 patients, we identify circular ecDNA in 82 patients (18%). Patients with ecDNA-positive medulloblastoma were more than twice as likely to relapse and three times as likely to die within ...